GAVILAX

Product NDC
17856-0312
11-digit product format
178560312
Labeler code
17856
Product ID
17856-0312_3a86670e-4e74-3a85-e063-6394a90ad435
Type
HUMAN OTC DRUG
Nonproprietary name
Polyethylene Glycol 3350
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Labeler
ATLANTIC BIOLOGICALS CORP.
Application
ANDA091077
Marketing category
ANDA
Marketing start
2021-01-26
Substance
POLYETHYLENE GLYCOL 3350
Active strength
17 g/17g
Pharmacologic classes
Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
GAVILAX
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
POLYETHYLENE GLYCOL 335017 g/17g

Harmonized Identifiers#

Field, Values table
FieldValues
UniiG2M7P15E5P
Rxcui876193, 876214

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
17856-0312-12025-03-04C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-22025-03-04C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-32025-03-04C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-42025-03-04C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-52025-03-04C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-62025-03-04C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-72025-03-04C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-12025-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-22025-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-32025-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-42025-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-52025-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-62025-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-72025-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-12023-10-10C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-22023-10-10C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-32023-10-10C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-42023-10-10C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-52023-10-10C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-62023-10-10C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-12023-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-22023-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-32023-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-42023-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-52023-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts
17856-0312-62023-01-30C16284748780-1f386c64a-1db9-0266-e053-dadaa90a7c1aGavilax Powder Solution Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
17856-0312-1GAVILAX17 g in 1 BAGPOWDER, FOR SOLUTION1714
17856-0312-2GAVILAX8.5 g in 1 BAGPOWDER, FOR SOLUTION8.514
17856-0312-3GAVILAX17 g in 1 CUPPOWDER, FOR SOLUTION1714
17856-0312-4GAVILAX4 g in 1 BAGPOWDER, FOR SOLUTION414
17856-0312-5GAVILAX8.5 g in 1 CUPPOWDER, FOR SOLUTION8.514
17856-0312-5GAVILAX50 in 1 CASEPOWDER, FOR SOLUTION5014
17856-0312-6GAVILAX72 in 1 CASEPOWDER, FOR SOLUTION7214
17856-0312-6GAVILAX4.5 g in 1 POUCHPOWDER, FOR SOLUTION4.514
17856-0312-7GAVILAX4.25 g in 1 BAGPOWDER, FOR SOLUTION4.2514
17856-0312-7GAVILAX50 in 1 BOX, UNIT-DOSEPOWDER, FOR SOLUTION5014
17856-0312-8GAVILAX72 in 1 BOX, UNIT-DOSEPOWDER, FOR SOLUTION7214
17856-0312-8GAVILAX4.25 g in 1 BAGPOWDER, FOR SOLUTION4.2514
17856-0312-9GAVILAX4.25 g in 1 CUPPOWDER, FOR SOLUTION4.2514
17856-0312-9GAVILAX50 in 1 BOX, UNIT-DOSEPOWDER, FOR SOLUTION5014

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
17856-0312-1EA - Each17856-03122207a097-3cbf-4c66-9606-5314f8ea385e12016-04-04
17856-0312-2EA - Each17856-0312461d158a-8bd4-4386-89f9-2aab4b3d5dd712016-04-04
17856-0312-5EA - Each17856-03127ad8a14d-8374-41b3-9796-93916cd3d28e12024-05-16
17856-0312-6EA - Each17856-031235018d5e-acba-4c4d-a224-fc921c1f7e2812025-06-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
17856-0312GAVILAX (POLYETHYLENE GLYCOL 3350) POWDER, FOR SOLUTION [ATLANTIC BIOLOGICALS CORP.]11Current NDC, Legacy NDC, 14 package rows20250529_c9688f06-b6db-4afb-b8ff-ef5fb8bf9946.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
876214GaviLAX 17 GM Powder for Oral SolutionPSNc9688f06-b6db-4afb-b8ff-ef5fb8bf994614
876193polyethylene glycol 3350 17 GM Powder for Oral SolutionPSNc9688f06-b6db-4afb-b8ff-ef5fb8bf994614
876214polyethylene glycol 3350 17000 MG Powder for Oral Solution [Gavilax]SBDc9688f06-b6db-4afb-b8ff-ef5fb8bf994614
876193polyethylene glycol 3350 17000 MG Powder for Oral SolutionSCDc9688f06-b6db-4afb-b8ff-ef5fb8bf994614
876214Gavilax 17 GM Powder for Oral SolutionSYc9688f06-b6db-4afb-b8ff-ef5fb8bf994614
876193polyethylene glycol 3350 17 GM Powder for Oral SolutionSYc9688f06-b6db-4afb-b8ff-ef5fb8bf994614

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
17856-0312-11785603120117 g in 1 BAG (17856-0312-1) 17 g2021-01-260000-00-00NoNoCurrent
17856-0312-2178560312028.5 g in 1 BAG (17856-0312-2) 8.5 g2021-01-260000-00-00NoNoCurrent
17856-0312-31785603120317 g in 1 CUP (17856-0312-3) 17 g2021-01-260000-00-00NoNoCurrent
17856-0312-4178560312044 g in 1 BAG (17856-0312-4) 4 g2021-01-260000-00-00NoNoCurrent
17856-0312-51785603120550 CUP in 1 CASE (17856-0312-5) / 8.5 g in 1 CUP50 cup2021-01-260000-00-00NoNoCurrent
17856-0312-61785603120672 POUCH in 1 CASE (17856-0312-6) / 4.5 g in 1 POUCH72 pouch2021-01-260000-00-00NoNoCurrent
17856-0312-71785603120750 BAG in 1 BOX, UNIT-DOSE (17856-0312-7) / 4.25 g in 1 BAG50 bag2023-10-10NoNoHistorical
17856-0312-81785603120872 BAG in 1 BOX, UNIT-DOSE (17856-0312-8) / 4.25 g in 1 BAG72 bag2025-07-22NoNoHistorical
17856-0312-91785603120950 CUP in 1 BOX, UNIT-DOSE (17856-0312-9) / 4.25 g in 1 CUP50 cup2025-07-22NoNoHistorical